| Literature DB >> 16439123 |
Mark E Fraley1, Robert M Garbaccio, Kenneth L Arrington, William F Hoffman, Edward S Tasber, Paul J Coleman, Carolyn A Buser, Eileen S Walsh, Kelly Hamilton, Christine Fernandes, Michael D Schaber, Robert B Lobell, Weikang Tao, Victoria J South, Youwei Yan, Lawrence C Kuo, Thomayant Prueksaritanont, Cathy Shu, Maricel Torrent, David C Heimbrook, Nancy E Kohl, Hans E Huber, George D Hartman.
Abstract
The evolution of 2,4-diaryl-2,5-dihydropyrroles as inhibitors of KSP is described. Introduction of basic amide and urea moieties to the dihydropyrrole nucleus enhanced potency and aqueous solubility, simultaneously, and provided compounds that caused mitotic arrest of A2780 human ovarian carcinoma cells with EC(50)s<10nM. Ancillary hERG activity was evaluated for this series of inhibitors.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16439123 DOI: 10.1016/j.bmcl.2006.01.030
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823